UNSPSC 41202012: Coccidioides immitisserological reagents

In this classification, Coccidioides immitis serological reagents are devices used in test to identify specific Coccidioides immitis antibodies in serum. US FDA regulates Coccidioides immitis serological reagents under 21 CFR 866.3135 and under FDA product code GMH.

UNSPSC 41202012 Coccidioides immitis serological reagents is a Commodity code covering immunoassay and molecular diagnostic supplies for infectious disease screening and confirmation testing. State and local governments soliciting under this code are primarily state health departments and county health services operations conducting routine and emergency procurements for communicable disease surveillance, public health laboratory operations, and clinical diagnostic services. The work spans reagent kits, calibrators, controls, consumables, and maintenance services for automated analyzer platforms; representative recent solicitations include the Illinois Department of Public Health's emergency procurement of Abbott HIV/Syphilis testing reagents and controls (May 2026, sole-source award to Abbott Laboratories for $38,079.50 to maintain CLIA certification at the Carbondale Laboratory), the City of Austin's IFB for Abbott Determine HIV 1/2 test kits (June 2026, estimated annual volume 375 test kits and 79 control kits), and the Illinois Department of Public Health's change order notice for Hologic NG/NT testing and kits (September 2026, IFB, response due October 13, 2026, increasing annual test volume from 15,000 to 25,000 tests and kit volume from 15,000 to 30,000 units, with contract cost adjusted upward by $375,000 to $900,000 over five years).

Recent activity concentrates in Illinois and Texas, with secondary presence in Georgia and California. The Illinois Department of Public Health, through its Chief Procurement Office for General Services, is a repeat issuer conducting multiple emergency and routine procurements for state-level laboratory reagent and maintenance services. Collin County, Texas has issued multiple related solicitations including an RFP for offender specimen collection and drug testing services (September 2026, response due July 23, estimated $600,000 over two years with three optional one-year renewals) and an IFB for general laboratory services (August 2026, deadline October 2, 2025, estimated $70,000 annually). Gwinnett County, Georgia solicited drug testing supplies compatible with an existing drugs of abuse analyzer (September 2026, response due October 14, 2026). The mix of issuing bodies — state health departments, county health and corrections departments, and city public health programs — reflects fragmented demand across disease surveillance, criminal justice supervision, and community health operations. Incumbent vendors holding state and regional contracts include Abbott Laboratories and Hologic; competitive opportunities exist for new entrants on routine IFBs, though sole-source emergency procurements restrict participation to existing equipment manufacturers and authorized distributors.